ESPR Net Income Growth
Esperion Therapeutics Inc · Net Income Growth
ESPR Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported95.16%period ending
ESPR TTM Net Income YoY % (9.59% → 95.16%)
Year-over-year change
High-resolution chart · PNG
ESPR net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 95.1554% | |
| 56.1658% | |
| -21.9659% | |
| -5.6093% | |
| -77.1209% | |
| 75.271% | |
| 58.3614% | |
| 55.6835% | |
| 63.7511% | |
| 10.4473% | |
| 14.345% | |
| 13.7063% | |
| -1.5934% | |
| 13.1728% | |
| 21.1285% | |
| 20.6326% | |
| -50.3511% | |
| -87.4651% | |
| -205.3474% | |
| -286.508% | |
| 40.5475% | |
| -47.7394% | |
| -6.0499% | |
| -9.3356% | |
| -284.7572% | |
| 51.8532% | |
| 46.9793% | |
| 56.1113% | |
| 60.4229% | |
| -20.853% | |
| -13.672% | |
| -34.3484% | |
| -70.98% | |
| -122.716% | |
| -167.2342% | |
| -138.7767% | |
| -90.7907% | |
| -50.6066% | |
| -28.2422% | |
| -26.4795% | |
| -32.3667% | |
| -36.8632% | |
| -25.9826% | |
| -34.5948% | |
| -34.4651% | |
| -39.4312% | |
| -90.9219% | |
| -85.3421% | |
| -119.65% | |
| -122.1829% | |
| -23.4695% | |
| 16.1364% | |
| 45.5519% | |
| -2.0105% | |
| -6.0824% | |
| -9.8122% | |
| -15.222% | |
| -17.7998% | |
| 3.2188% | |
| 9.0459% | |
| 9.5922% |